---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-143202"
form_type: "8-K"
ticker: "KLRS"
cik: "0001754068"
company_name: "Kalaris Therapeutics, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:36:35.807018+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Kalaris sets Aug 12, 2025 annual meeting; stockholder proposals due June 30

## Summary
- 2025 annual meeting scheduled for August 12, 2025; postponed from typical anniversary date.
- Rule 14a-8 stockholder proposals must be received by June 30, 2025 to be included in proxy materials.
- Director nominations under by-laws also due June 30, 2025, as meeting delayed over 60 days from prior year.

## SEC filing metadata
- accession: 0001193125-25-143202
- form_type: 8-K
- ticker: KLRS
- cik: 0001754068
- company_name: Kalaris Therapeutics, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1754068/000119312525143202/0001193125-25-143202-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1754068/000119312525143202/d45802d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-143202
- JSON: https://secwatch.observer/filing/0001193125-25-143202.json
- Plain text: https://secwatch.observer/filing/0001193125-25-143202.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.